Description
The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT) platform, this app enables participants to engage in clinical studies outside the traditional trial setting—from the comforts of home and as they go about their daily lives. The app’s features allow participants to provide consent, complete study tasks, report changes in health or medication, and communicate with the study team, all from the convenience of their personal iOS.
Hide
Show More...
Screenshots
ObvioGo 2.0 FAQ
-
Is ObvioGo 2.0 free?
Yes, ObvioGo 2.0 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is ObvioGo 2.0 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ObvioGo 2.0 cost?
ObvioGo 2.0 is free.
-
What is ObvioGo 2.0 revenue?
To get estimated revenue of ObvioGo 2.0 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Australia yet.
Ratings History
ObvioGo 2.0 Reviews
No Reviews in Australia
App doesn't have any reviews in Australia yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
ObvioGo 2.0 Installs
Last 30 days
ObvioGo 2.0 Revenue
Last 30 daysObvioGo 2.0 Revenue and Downloads
Gain valuable insights into ObvioGo 2.0 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Obvio Health USA
- Languages
- English, Spanish
- Recent release
- 2.1.0 (3 weeks ago )
- Released on
- May 10, 2024 (8 months ago )
- Also available in
- United States, Pakistan, Italy, Japan, Kuwait, Mexico, Malaysia, Netherlands, Norway, New Zealand, Peru, Philippines, India, Poland, Portugal, Romania, Russia, Singapore, Thailand, Ukraine, Vietnam, South Africa, Germany, Australia, Azerbaijan, Belgium, Brazil, Canada, Switzerland, Chile, China, Colombia, Czechia, Argentina, Denmark, Algeria, Finland, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.